Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Pharmacology and Experimental Therapeutics
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Journal of Pharmacology and Experimental Therapeutics

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit jpet on Facebook
  • Follow jpet on Twitter
  • Follow jpet on LinkedIn
Research ArticleArticle

THE EFFECT OF ACETAZOLAMIDE AND FUROSEMIDE ON CEREBROSPINAL FLUID PRODUCTION AND CHOROID PLEXUS CARBONIC ANHYDRASE ACTIVITY

Ken D. McCarthy and Donal J Reed
Journal of Pharmacology and Experimental Therapeutics April 1974, 189 (1) 194-201;
Ken D. McCarthy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Donal J Reed
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
  • eLetters
  • PDF
Loading

Abstract

The ability of acetazolamide and furosemide to inhibit cerebrospinal fluid (CSF) flow and choroid plexus carbonic anhydrase was measured in adult New Zealand White rabbits of either sex. CSF formation rates were measured by the inulin-dilution technique and carbonic anhydrase activity by the changing-pH method. The maximal reduction in CSF flow with either drug was between 50 and 60%. Acetazolamide did not decrease CSF flow rate until over 99.5% of choroid plexus carbonic anhydrase was inhibited. In contrast, furosemide caused a significant decrease in CSF flow with less than 98% inhibition of choroid plexus carbonic anhydrase. In vitro studies showed that acetazolamide is about 100 times as potent as furosemide in the inhibition of carbonic anhydrase of the choroid plexus. Based on the assumption that the decrease in CSF flow with acetazolamide is due solely to carbonic anhydrase inhibition, then furosemide must be acting, at least partially, by a mechanism other than the inhibition of choroid plexus carbonic anhydrase. If acetazolamide and furosemide decrease flow by different mechanisms, the effects of the two drugs may be additive with respect to inhibition of CSF flow and it may be possible to reduce CSF flow more than the approximately 50% that can be accomplished with the individual therapeutic agents presently in use.

Footnotes

    • Received June 25, 1973.
    • Accepted December 17, 1973.
  • © 1974 by The Williams & Wilkins Company

JPET articles become freely available 12 months after publication, and remain freely available for 5 years. 

Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page. 

 

  • Click here for information on institutional subscriptions.
  • Click here for information on individual ASPET membership.

 

Log in using your username and password

Forgot your user name or password?

Purchase access

You may purchase access to this article. This will require you to create an account if you don't already have one.
PreviousNext
Back to top

In this issue

Journal of Pharmacology and Experimental Therapeutics
Vol. 189, Issue 1
1 Apr 1974
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Editorial Board (PDF)
  • Front Matter (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Journal of Pharmacology and Experimental Therapeutics article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
THE EFFECT OF ACETAZOLAMIDE AND FUROSEMIDE ON CEREBROSPINAL FLUID PRODUCTION AND CHOROID PLEXUS CARBONIC ANHYDRASE ACTIVITY
(Your Name) has forwarded a page to you from Journal of Pharmacology and Experimental Therapeutics
(Your Name) thought you would be interested in this article in Journal of Pharmacology and Experimental Therapeutics.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Research ArticleArticle

THE EFFECT OF ACETAZOLAMIDE AND FUROSEMIDE ON CEREBROSPINAL FLUID PRODUCTION AND CHOROID PLEXUS CARBONIC ANHYDRASE ACTIVITY

Ken D. McCarthy and Donal J Reed
Journal of Pharmacology and Experimental Therapeutics April 1, 1974, 189 (1) 194-201;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Research ArticleArticle

THE EFFECT OF ACETAZOLAMIDE AND FUROSEMIDE ON CEREBROSPINAL FLUID PRODUCTION AND CHOROID PLEXUS CARBONIC ANHYDRASE ACTIVITY

Ken D. McCarthy and Donal J Reed
Journal of Pharmacology and Experimental Therapeutics April 1, 1974, 189 (1) 194-201;
Reddit logo Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • PST3093 Stimulates SERCA2a and Improves Cardiac Function
  • CRV431 Decreases Liver Fibrosis and Tumor Development
  • Down-Regulation of Rat Hepatic Microsomal Cytochromes P-450 in Microvesicular Steatosis Induced by Orotic Acid
Show more Article

Similar Articles

Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About JPET
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0103 (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics